Company Affymax, Inc. Nasdaq
Equities
US00826A1097
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Sales per Business
USD in Million | 2012 | Weight | 2013 | Weight | Delta |
---|---|---|---|---|---|
Collaboration
99.6
%
| - | - | 1 | 99.6 % | - |
License and Royalty
0.4
%
| - | - | 0 | 0.4 % | - |
Sales per region
USD in Million | 2012 | Weight | 2013 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 94 | 100.0 % | 1 | 100.0 % | -98.55% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 37,490,095 | 37,490,095 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B |
- Stock Market
- Equities
- AFFY Stock
- Stock
- Company Affymax, Inc.